Jason Winner
commented on
$Super Micro Computer (SMCI.US)$
Currently, the pre-market is at 46.5. Do you want to enter at the current value?
Currently, the pre-market is at 46.5. Do you want to enter at the current value?
Translated
1
15
Jason Winner
liked
$Intel (INTC.US)$
Intel's (INTC) stock has mixed projections for the next year, with analysts generally forecasting moderate upside but emphasizing uncertainty due to industry challenges.
1. Analyst Forecasts: The average price target for Intel over the next 12 months is $25.78, reflecting a potential 23% increase from the current price of about $20.92. Price targets range widely, from a low of $20.20 to a high of $61.46, highlighting differing opinions on Intel's recovery potential.
2. Performan...
Intel's (INTC) stock has mixed projections for the next year, with analysts generally forecasting moderate upside but emphasizing uncertainty due to industry challenges.
1. Analyst Forecasts: The average price target for Intel over the next 12 months is $25.78, reflecting a potential 23% increase from the current price of about $20.92. Price targets range widely, from a low of $20.20 to a high of $61.46, highlighting differing opinions on Intel's recovery potential.
2. Performan...
7
$GENTING (3182.MY)$ Much more than Casino. They have cash, they can hire smart people's, buy companies, invest in other industries. time will tell.
Jason Winner
liked
$GENTING (3182.MY)$
Genting's investment in TauRx Pharmaceuticals focuses on the development of hydromethylthionine mesylate (HMTM), not a vaccine. HMTM is a drug designed to treat Alzheimer's disease .The drug recently completed Phase 3 clinical trials, showing promising results such as slowed cognitive decline and a strong safety profile.
The regulatory process has begun, with submissions made to the UK Medicines and Healthcare Products Regulatory Age...
Genting's investment in TauRx Pharmaceuticals focuses on the development of hydromethylthionine mesylate (HMTM), not a vaccine. HMTM is a drug designed to treat Alzheimer's disease .The drug recently completed Phase 3 clinical trials, showing promising results such as slowed cognitive decline and a strong safety profile.
The regulatory process has begun, with submissions made to the UK Medicines and Healthcare Products Regulatory Age...
8
2
Jason Winner
liked
$Super Micro Computer (SMCI.US)$ stated it settled dues to bank. I also want to pay my bills, thank you! In $Super Micro Computer (SMCI.US)$ we trust to fail
9
1
Jason Winner
commented on
Jason Winner
commented on
Jason Winner
liked
$TOPGLOV (7113.MY)$ if this week the price break rm1.45 , huat ah everyone! Top glove share price already out perform my conservative target.
3
Jason Winner : yes, if you believe it will hit usd60 and above.
Jason Winner Yumi Liu OP : I hope you are right too. I believe in you. don't buy too much!